Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
symbol | company | %chng | last | %short | avg$volume | |
---|---|---|---|---|---|---|
MRNA | Moderna, Inc. | -1.47% | 131.02 | 0.0% | $2314.17m | |
BNGO | BioNano Genomics, Inc. | 18.50% | 9.80 | 0.0% | $2016.46m | |
GILD | Gilead Sciences, Inc. | -0.06% | 66.94 | 1.0% | $649.72m | |
AMGN | Amgen, Inc. | 0.58% | 253.50 | 1.3% | $564.60m | |
CRSP | CRISPR Therapeutics AG | 1.83% | 188.49 | 0.6% | $487.99m | |
REGN | Regeneron Pharmaceuticals, Inc. | 0.43% | 537.78 | 2.7% | $478.09m | |
ALXN | Alexion Pharmaceuticals, Inc. | 1.19% | 159.73 | 2.0% | $470.59m | |
NVAX | Novavax, Inc. | 3.74% | 126.98 | 92.9% | $417.43m | |
ILMN | Illumina, Inc. | 0.34% | 406.25 | 3.5% | $396.72m | |
SRPT | Sarepta Therapeutics, Inc. | 1.36% | 98.24 | 13.8% | $364.79m | |
VRTX | Vertex Pharmaceuticals, Inc. | -0.44% | 237.59 | 1.9% | $361.85m | |
BIIB | Biogen, Inc. | -0.25% | 269.44 | 1.7% | $321.90m | |
BNTX | BioNTech SE | 2.86% | 108.44 | 0.0% | $298.33m | |
EXAS | EXACT Sciences Corp. | 1.30% | 150.00 | 19.6% | $243.95m | |
PACB | Pacific Biosciences of California, Inc. | 3.06% | 37.42 | 7.4% | $228.17m |
Company Profile
Aptevo Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on developing novel immunotherapies for the treatment of cancer. Its pipeline APVO436, ALG.APV-527 and APVO603 were developed based on the ADAPTIR modular protein platform technology and APVO442 was developed based on the new ADAPTIR-FLE platform technology. The ADAPTIR and ADAPTIR-FLEX are capable of generating differentiated bispecific and multi-specific antibodies with potentially unique mechanisms of action for the treatment of different types of cancer. The company was founded on February 22, 2016 and is headquartered in Seattle, WA.